JSE LIMITED - Dealings in securities by directors, prescribed officers, the Company Secretary and the JSE LTIS 2018 Trust

Dealings in securities by directors, prescribed officers, the Company Secretary and the JSE LTIS 2018 Trust

JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
("JSE")

DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY
SECRETARY AND THE JSE LTIS 2018 TRUST

The JSE LTIS 2018 Trust ("Trust") has acquired 781 870 JSE ordinary shares
in the open market on behalf of executive directors, prescribed officers,
the Company Secretary, and senior members of staff ("LTIS 2018
participants") in respect of share awards granted in March 2024 to these
LTIS 2018 participants under the JSE's Long-Term Incentive Scheme ("LTIS
2018"). The ordinary shares are held by the LTIS 2018 participants on a
direct beneficial basis.

These ordinary shares are restricted until all vesting criteria are
fulfilled whereupon the shares will vest in the hands of LTIS 2018
participants. To the extent that the vesting criteria are not fulfilled,
the share awards are forfeited.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) the LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively "the vesting criteria").

These JSE ordinary shares were acquired on-market, with prior clearance and
at a volume-weighted average price ("VWAP") of R89.61 per ordinary share.
The total transaction value amounted to R70 061 395. The daily high, low
and volume-weighted average price for the various transactions effected by
the Trust were –

                 Number of JSE   Daily VWAP of   Daily highest   Daily lowest
 Dates in 2024   ordinary        JSE shares      price paid      price paid
 that JSE        shares          acquired        (cents per      (cents per
 ordinary        acquired        (cents per      share)          share)
 shares were                     share)
 acquired

 18 March        193 624         8851.36         8855            8765
 19 March        117 683         9146.27         9206            8948
 20 March        470 563         8959.36         9250            8964

The requisite approvals have been granted by shareholders at the JSE's
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these ordinary shares.

ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS
AND THE COMPANY SECRETARY

Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, the prescribed officers and the
Company Secretary have, on 20 March 2024, accepted grants of restricted JSE
ordinary shares, as reflected below.


  Executive      Role            Total number    Total Rand value    Nature of
                                 of restricted   of restricted JSE   interest
                                 JSE ordinary    ordinary shares
                                 shares          awarded and
                                 awarded and     accepted
                                 accepted
  
  L Fourie       Group CEO &     148 310         13 290 059          Direct
                 Executive                                           beneficial
                 Director
  F Suliman      Group CFO &     60 080          5 383 768           Direct
                 Executive                                           beneficial
                 Director
  A Greenwood    Prescribed      58 398          5 233 044           Direct
                 Officer                                             beneficial
  V Lee          Prescribed      31 082          2 785 258           Direct
                 Officer                                             beneficial
  I Monale       Prescribed      45 394          4 067 756           Direct
                 Officer                                             beneficial
  Q Mthembu      Prescribed      20 830          1 866 576           Direct
                 Officer                                             beneficial
  M Randall      Prescribed      49 144          4 403 793           Direct
                 Officer                                             beneficial
  T Tsoaeli      Prescribed      40 804          3 656 446           Direct
                 Officer                                             beneficial
  V Reddy        Prescribed      64 886          5 814 434           Direct
                 Officer                                             beneficial
  GA Brookes     Group Company   16 040          1 437 344           Direct
                 Secretary                                           beneficial

The restricted shares will vest in two tranches, one-half on 1 March 2027
and the remaining half on 1 March 2028, subject to the vesting criteria as
set out above being met.

The individual allocations (grant and acceptance) were approved by the JSE's
Group Remuneration Committee and clearance to deal was granted by the
Chairman of the Board.

Sandton
22 March 2024

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 22-03-2024 05:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.